Discovery Discovery Expense Discovery Expense Accrued compute liabilities Accrued Compute Liabilities, Current Accrued Compute Liabilities, Current Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Prepaid expenses License Agreement, Increase (Decrease) Accrued Liabilities License Agreement, Increase (Decrease) Accrued Liabilities Restricted cash Restricted Cash, Current Award Timing Predetermined Award Timing Predetermined [Flag] Equity interest issued or issuable (in shares) Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares Intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) Entity File Number Entity File Number Additional Paid-in-Capital Additional Paid-in Capital [Member] Phenomaps Raw Images Phenomaps Raw Images [Member] Phenomaps Raw Images Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Decrease in cash related to disposal of a business Proceeds from Divestiture of Businesses, Net of Cash Divested Accounts payable Increase (Decrease) in Accounts Payable Cost incurred Contract with Customer, Asset, after Allowance for Credit Loss, Current Dividends declared Dividends, Stock Interest income, net Interest Income (Expense), Nonoperating Stock based compensation Share-Based Payment Arrangement [Member] Goodwill [Line Items] Goodwill [Line Items] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Measurement Basis [Axis] Measurement Basis [Axis] Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share) Net loss per share, basic (in dollars per shares) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] License agreement, term License Agreement, Term License Agreement, Term Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit Schedule of Segment Reporting Information, by Segment [Table Text Block] Remaining performance obligation revenue Revenue, Remaining Performance Obligation, Amount Adjustment to Compensation, Amount Adjustment to Compensation Amount Cash paid for amount included in the measurement of lease liabilities: Cash Paid For Amount Included In The Measurement Of Lease Liabilities [Abstract] Cash Paid For Amount Included In The Measurement Of Lease Liabilities Other receivables and assets Increase (Decrease) in Other Operating Assets Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Employee Stock Option Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Insider Trading Policies and Procedures [Line Items] Total Share-Based Payment Arrangement, Expense Sale of stock, value authorized Sale Of Stock, Value, Authorized Sale Of Stock, Value, Authorized Common stock, shares authorized (in shares) Common Stock, Shares Authorized Goodwill and Intangible Assets Disclosure [Abstract] Common stock sales issuances, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Current assets Assets, Current [Abstract] Total liabilities and stockholders’ equity Liabilities and Equity Consumables Consumable Expense Consumable Expense Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Definite-lived licensed intangible assets Licensing Agreements [Member] Materials received not invoiced Materials Received Not Invoiced Materials Received Not Invoiced Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Cover [Abstract] Cash and cash equivalents: Cash and Cash Equivalents, Fair Value Disclosure Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Maximum Maximum [Member] General and administrative General and Administrative Expense [Member] Total expenditures for additions to long-lived assets Segment, Expenditure, Addition to Long-Lived Assets Accounting Policies [Abstract] Net carrying amount Finite-Lived Intangible Assets, Net Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Fair market value of vested shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Accrued development expenses Accrued Development Costs, Current Accrued Development Costs, Current Currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Acquisitions Business Combination [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before income tax benefit Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Other liabilities, non-current Other Liabilities, Noncurrent Goodwill impairment Goodwill, Impairment Loss Statement of Stockholders' Equity [Abstract] Remaining operating lease term Lessee, Operating Lease, Remaining Lease Term Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Interest income Investment Income, Nonoperating Disposal Group Name [Domain] Disposal Group Name [Domain] Name Measure Name Annual payments License Agreement, Annual Payments License Agreement, Annual Payments Research project, fees and milestones payments receivable for an option on a lead series Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liabilities Operating Lease, Liability, Current Class of Stock [Line Items] Class of Stock [Line Items] Deferred tax liabilities Deferred Income Tax Liabilities, Net Document Fiscal Period Focus Document Fiscal Period Focus Intangible assets, foreign currency translation gain (loss) Intangible Assets, Foreign Currency Translation Gain (Loss) Intangible Assets, Foreign Currency Translation Gain (Loss) Award Timing Method Award Timing Method [Text Block] Exscientia GmbH Exscientia GmbH [Member] Exscientia GmbH Award Type [Axis] Award Type [Axis] Unearned revenue, non-current Contract with Customer, Liability, Noncurrent Total assets Assets Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Investment, Name [Domain] Investment, Name [Domain] Book values Portion at Other than Fair Value Measurement [Member] Trading Symbol Trading Symbol Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value 2024 Inducement Equity Incentive Plan 2024 Inducement Equity Incentive Plan [Member] 2024 Inducement Equity Incentive Plan Aggregate amount payable in cash or equity License Agreement, Aggregate Payments License Agreement, Aggregate Payments Accrued early discovery expenses Accrued Early Discovery Expenses, Current Accrued Early Discovery Expenses, Current Stock option exercises and other (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other segment items Segment Reporting, Other Segment Item, Amount Revenue, Remaining Performance Obligation [Axis] Revenue, Remaining Performance Obligation [Axis] Revenue, Remaining Performance Obligation Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] RSUs Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Purchase of an intangible asset Payments to Acquire Intangible Assets Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Equity method investments Equity Method Investments Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Number of performance obligations under the agreement (in performance obligations) Revenue, Performance Obligation, Number Of Obligations Revenue, Performance Obligation, Number Of Obligations Common sock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Plan Name [Axis] Plan Name [Axis] Restricted cash Restricted Cash And Cash Equivalents, Fair Value Disclosure Restricted Cash And Cash Equivalents, Fair Value Disclosure Document Information [Table] Document Information [Table] PEO PEO [Member] Supplemental schedule of non-cash investing and financing activities Noncash Investing and Financing Items [Abstract] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Merck KGaA (Merck) Merck KGaA (Merck) [Member] Merck KGaA (Merck) Accumulated Deficit Retained Earnings [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income tax benefit Income tax benefit Income Tax Expense (Benefit) Class B Common Stock Class B Common Class B [Member] Sale of Stock [Domain] Sale of Stock [Domain] Repayment of long-term debt and finance lease liabilities Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security Document Information [Line Items] Document Information [Line Items] Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Sanofi Sanofi [Member] Sanofi Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total liabilities Liabilities, Fair Value Disclosure Business Combination [Table] Business Combination [Table] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Supplemental Financial Information Supplemental Balance Sheet And Income Statement Information [Text Block] Supplemental Balance Sheet And Income Statement Information Notes Payable Notes Payable, Other Payables [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued expenses and other liabilities Accrued expense and other liabilities Accrued Liabilities, Current Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative General and Administrative Expense Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Cost of revenue Cost of Sales [Member] Goodwill Goodwill, beginning balance Goodwill, ending balance Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of Components of Lease Cost and Supplemental Cash Flow Information Related to Leases and Lease Term and Discount Rates Lease, Cost [Table Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Money market funds Money Market Funds [Member] Sale of stock, value remaining authorized Sale Of Stock Value Remaining Authorized Sale Of Stock Value Remaining Authorized Asset impairment Tangible Asset Impairment Charges Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Equity Components [Axis] Equity Components [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Description of the Business Nature of Operations [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Neuroscience Neuroscience [Member] Neuroscience Other Performance Measure, Amount Other Performance Measure, Amount Entity Address, State or Province Entity Address, State or Province Financing cash flows from financing leases Finance Lease, Principal Payments Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Total current liabilities Liabilities, Current Individual: Individual [Axis] Milestone, Type [Domain] Milestone, Type [Domain] Milestone, Type [Domain] Leases Lessee, Finance Leases [Text Block] Other current assets Other Assets, Current Research and development Research and Development Expense [Member] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Loss on disposal of a business Gain (Loss) on Disposition of Business Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Number of eligible phenomaps Contract With Customer, Maximum Accepted Product Contract With Customer, Maximum Accepted Product Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Plan Name [Domain] Plan Name [Domain] Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Equity [Abstract] Gastrointestinal Cancer Gastrointestinal Cancer [Member] Gastrointestinal Cancer Roche and Genentech Roche and Genentech [Member] Roche and Genentech Segment Information Segment Reporting Disclosure [Text Block] Goodwill [Table] Goodwill [Table] Notes payable and financing lease liabilities Notes payable and financing lease liabilities, current Long-Term Debt and Lease Obligation, Current Business days prior to the payment date License Agreement, Amount Of Time Prior To The Payment Date License Agreement, Amount Of Time Prior To The Payment Date Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Amortization expense Amortization of Intangible Assets Deferred tax assets Deferred Income Tax Assets, Net Depreciation and amortization Depreciation, Depletion and Amortization Other assets, non-current Other Assets, Noncurrent Significant segment expenses Significant Segment Expenses [Abstract] Significant Segment Expenses Entity Central Index Key Entity Central Index Key PEO Name PEO Name TD Cowen Sales Agreement At-The-Market Offering Program TD Cowen [Member] At-The-Market Offering Program TD Cowen Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Finance lease liability Finance Lease, Liability Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] RE Ventures I RE Ventures I [Member] RE Ventures I Unearned revenue Contract with Customer, Liability, Current Segments [Axis] Segments [Axis] Grant revenue Grant [Member] Increase (decrease) in operating lease liabilities Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Accrued development expense Increase (Decrease) In Accrued Development Expense Increase (Decrease) In Accrued Development Expense Local Phone Number Local Phone Number Class of Stock [Domain] Class of Stock [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Foreign income tax expense (benefit) Foreign Income Tax Expense (Benefit), Continuing Operations Assets Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurements Fair Value Disclosures [Text Block] Business Combination [Line Items] Business Combination [Line Items] Gross carrying amount Finite-Lived Intangible Assets, Gross Stockholders’ equity Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Research and development Research and Development Expense Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Investment, Name [Axis] Investment, Name [Axis] Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent Shares issued in the period, upon conversion (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Collaborative Arrangement Collaborative Arrangement [Member] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Salaries Labor and Related Expense Valence Discovery Inc Valence Discovery Inc [Member] Valence Discovery Inc Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Purchases of investments Payments to Acquire Investments Total operating costs and expenses Costs and Expenses Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Document Quarterly Report Document Quarterly Report Total Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Platform Platform Fee Expense Platform Fee Expense Counterparty Name [Domain] Counterparty Name [Domain] Number of operating segments Number of Operating Segments Common stock, conversion ratio Common Stock, Conversion Ratio Common Stock, Conversion Ratio Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Schedule of Accrued Expenses and Other Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Supplemental asset information Supplemental Asset Information [Abstract] Supplemental Asset Information Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Lease liabilities Increase (Decrease) In Lease Liability Increase (Decrease) In Lease Liability Restatement Determination Date: Restatement Determination Date [Axis] Stock option exercises and other Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Non-PEO NEO Non-PEO NEO [Member] Sale of Stock [Axis] Sale of Stock [Axis] Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] Equity Awards Adjustments Equity Awards Adjustments [Member] Other, net Other Noncash Income (Expense) Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Statement of Comprehensive Income [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Fair values Estimate of Fair Value Measurement [Member] Revenue recognized Contract with Customer, Liability, Revenue Recognized MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Restricted cash, non-current Restricted Cash, Noncurrent Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Revenue Revenues [Abstract] Exchangeable Stock Exchangeable Stock [Member] Exchangeable Stock Equity incentive plans Proceeds From (Payment For) Share-Based Payment Arrangement Proceeds From (Payment For) Share-Based Payment Arrangement Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accrued license fees Accrued License Fee, Current Accrued License Fee, Current Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Notes payable and financing lease liabilities, non-current Notes payable and financing lease liabilities, non-current Long-Term Debt and Lease Obligation Tempus agreement Tempus Agreement [Member] Tempus Agreement Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Minimum Minimum [Member] Company Selected Measure Name Company Selected Measure Name Fair Value Measurement [Domain] Fair Value Measurement [Domain] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Operating cash flows from operating leases Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Discovery, Development And Sales Milestones Discovery, Development And Sales Milestones [Member] Discovery, Development And Sales Milestones All Executive Categories All Executive Categories [Member] Milestone, Type [Axis] Milestone, Type [Axis] Milestone, Type Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of March 31, 2026 and December 31, 2025; 530,628,653 shares (Class A 524,464,320, Class B 5,307,334 and Exchangeable 856,999) and 528,182,693 shares (Class A 521,831,046, Class B 5,547,334 and Exchangeable 804,313) issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Financing lease right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Goodwill [Roll Forward] Goodwill [Roll Forward] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares) Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (Note 7) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Business Combination [Axis] Business Combination [Axis] Entity Small Business Entity Small Business Interest acquired Asset Acquisition, Equity Ownership, Percentage Asset Acquisition, Equity Ownership, Percentage Income Tax Disclosure [Abstract] Document Transition Report Document Transition Report Equity method investment ownership percentage Equity Method Investment, Ownership Percentage Schedule of Financial Instruments Not Measured at Fair Value Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block] Underlying Securities Award Underlying Securities Amount Vote per share of common stock (in votes) Common Stock, Vote Per Share Common Stock, Vote Per Share Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Income Taxes Income Tax Disclosure [Text Block] Class A Common Stock Class A Common Class A [Member] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Alpha Biotechnology GmbH (Alpha) Alpha Biotechnology GmbH (Alpha) [Member] Alpha Biotechnology GmbH (Alpha) Research Milestones Research Milestones [Member] Research Milestones Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Asset Acquisition [Domain] Asset Acquisition [Domain] Proceeds from issuance of common shares, net of issuance costs Proceeds from Issuance of Common Stock Total revenue Revenue Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Tempus Labs, Inc Tempus Labs, Inc [Member] Tempus Labs, Inc Fair Value Disclosures [Abstract] Purchase of an equity investment Purchase Of An Equity Investment, Non-Cash Purchase Of An Equity Investment, Non-Cash Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Asset acquisition, consideration transferred Asset Acquisition, Consideration Transferred Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Loss contingency accrual Loss Contingency Accrual Other receivables Other Receivables, Net, Current Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Foreign currency translation adjustments Goodwill, Foreign Currency Translation, Gain (Loss) Disposal Group Name [Axis] Disposal Group Name [Axis] Payments to acquire IPR&D Payments to Acquire in Process Research and Development Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Prepaid data assets Increase (Decrease) In Prepaid Data Assets Increase (Decrease) In Prepaid Data Assets Other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities Liabilities, Current [Abstract] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Operating revenue License and Service [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share) Net loss per share, diluted (in dollars per shares) Earnings Per Share, Diluted Accrued expenses and other current liabilities Increase (Decrease) in Other Accrued Liabilities Depreciation and amortization Cost, Depreciation and Amortization Increase (decrease) in operating lease right-of-use assets Operating leases Increase (Decrease) in Operating Lease Right-Of-Use Assets Increase (Decrease) in Operating Lease Right-Of-Use Assets Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Title of 12(b) Security Title of 12(b) Security Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Per share data Earnings Per Share [Abstract] Other income (loss), net Other non-operating income (loss), net Nonoperating Income (Expense) Namandjé Bumpus [Member] Namandjé Bumpus Developed and Commercialized Programs Developed And Commercialized Programs [Member] Developed And Commercialized Programs Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Interest Income, Net Interest Income and Interest Expense Disclosure [Table Text Block] Unearned revenue Increase (Decrease) in Contract with Customer, Liability Reportable Segment Reportable Segment [Member] Reportable Segment Phenomaps Creation Phenomaps Creation [Member] Phenomaps Creation Registration rights agreement term Registration Rights Agreement, Term Registration Rights Agreement, Term Schedule of RSU Activity Nonvested Restricted Stock Shares Activity [Table Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Award Timing Disclosures [Line Items] Accrued compensation Employee-related Liabilities, Current Operating lease, renewal term Lessee, Operating Lease, Renewal Term Common Stock Equity [Text Block] Net loss Net loss Net loss Total segment loss Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Accrued other expenses Other Accrued Liabilities, Current Stock options, vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Adoption Date Trading Arrangement Adoption Date Clinical development Clinical Development Expense Clinical Development Expense Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Loss from operations Operating Income (Loss) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Development And Regulatory Milestones Development And Regulatory Milestones [Member] Development And Regulatory Milestones Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Impairment of indefinite-lived intangible assets Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Current Fiscal Year End Date Current Fiscal Year End Date Class of Stock [Axis] Class of Stock [Axis] Definite-lived technology intangible assets Technology-Based Intangible Assets [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Trading period used for equity value determination License Agreement, Trading Period Used For Equity Value Determination License Agreement, Trading Period Used For Equity Value Determination Weighted-average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Purchase of an intangible asset Noncash or Part Noncash Acquisition, Intangible Assets Acquired Deferred income taxes Deferred Income Tax Expense (Benefit) Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Collaborative Development Contracts Collaborative Arrangement Disclosure [Text Block] Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash Cash [Member] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Remaining unearned revenue Contract with Customer, Liability Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Antidilutive securities excluded from computation of loss per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Amendment Flag Amendment Flag Number of projects that may be initiated Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash provided by (used in) financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Basis of Presentation Basis of Presentation and Significant Accounting Policies [Text Block] Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares) Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Cost of revenue Cost of Product and Service Sold Disposal Group Classification [Domain] Disposal Group Classification [Domain] Schedule of Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Segment Reporting [Abstract] Number of classes of common stock authorized Number Of Classes Of Common Stock Authorized Number Of Classes Of Common Stock Authorized Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Lease expense Operating Lease, Expense Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number Asset Acquisition [Axis] Asset Acquisition [Axis] Revenue, Remaining Performance Obligation [Domain] Revenue, Remaining Performance Obligation [Domain] Revenue, Remaining Performance Obligation [Domain] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Right-of-use assets additions, modifications and termination: Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract] Right-Of-Use Assets Obtained In Exchange For Lease Liabilities Operating cash flows from financing leases Finance Lease, Interest Payment on Liability Interest expense Interest Expense, Nonoperating Schedule of Goodwill Schedule of Goodwill [Table Text Block] Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Maximum number of novel small molecule candidates Contract With Customer, Number Of Novel Small Molecule Candidates Contract With Customer, Number Of Novel Small Molecule Candidates Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Stock units Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Accrued property and equipment Capital Expenditures Incurred but Not yet Paid 2021 Equity Incentive Plan 2021 Equity Incentive Plan [Member] 2021 Equity Incentive Plan Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating costs and expenses Operating Expenses [Abstract] Prepaid data assets Prepaid Expense, Current Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Finance leases, assets pledged as collateral Finance Leases, Assets Pledged As Collateral Finance Leases, Assets Pledged As Collateral Common stock sales issuances, net of issuance costs Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Supplemental Financial Information [Abstract] Supplemental Financial Information Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Common Stock (Class A, B and Exchangeable) Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Accrued professional fees Accrued Professional Fees, Current